Acquired von Willebrand Syndrome in Patients With a Centrifugal or Axial Continuous Flow Left Ventricular Assist Device

被引:186
作者
Meyer, Anna L. [1 ]
Malehsa, Doris [2 ]
Budde, Ulrich [3 ]
Bara, Christoph [2 ]
Haverich, Axel [2 ]
Strueber, Martin [1 ]
机构
[1] Univ Leipzig, Ctr Heart, Clin Heart Surg, D-04289 Leipzig, Germany
[2] Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, Hannover, Germany
[3] AescuLab Hamburg, Hamburg, Germany
关键词
bleeding; HeartMate II; HeartWare; LVAD; von Willebrand syndrome; HEART-TRANSPLANTATION; CIRCULATORY SUPPORT; PROTEOLYSIS; STENOSIS; DISEASE; PUMP;
D O I
10.1016/j.jchf.2013.10.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives The aim of this study was to determine whether differences in continuous flow left ventricular assist devices (LVADs) may lead to differences in the von Willebrand profile and the occurrence of bleeding and thromboembolic events. Background The HeartMate II (Thoratec Corp., Pleasanton, California) and HeartWare Ventricular Assist Device (HVAD) (HeartWare, Inc., Framingham, Massachusetts) systems are the most frequently implanted LVADs worldwide. In all patients with an axial-flow HeartMate II, acquired von Willebrand syndrome (AvWS) due to the loss of large molecular weight multimers was found. The large molecular weight multimers of the von Willebrand factor (vWF) play a key role in primary hemostasis through interactions with platelets. Methods This was a retrospective study of the vWF profile and incidence of bleeding and thromboembolic events in 102 patients receiving the HeartMate II (n = 51) and HVAD (n = 51). Between January 2003 and December 2010, vWF testing was performed in 102 of 175 consecutive patients after LVAD implantation. Results AvWS was found in all patients, demonstrated by a decrease in the high molecular weight multimers of vWF to 30 +/- 14% in HeartMate II patients and 34 +/- 13% in patients with an HVAD. Significant predictors of vWF antigen included age (p = 0.011), number of days on the device (p = 0.035), C-reactive protein (p < 0.001), and blood group (p = 0.007). Bleeding and thromboembolic event rates were similar. However, lower fractions of vWF antigen and high molecular weight multimers did not correlate with the rate of bleeding complications or thromboembolic events. Conclusions AvWS developed in all patients after centrifugal or axial flow pump implantation. Different patterns of AvWS were seen between the devices as well as individually. However, the complication rates after implantation were similar. (C) 2014 by the American College of Cardiology Foundation
引用
收藏
页码:141 / 145
页数:5
相关论文
共 18 条
[1]   Use of an Intrapericardial, Continuous-Flow, Centrifugal Pump in Patients Awaiting Heart Transplantation [J].
Aaronson, Keith D. ;
Slaughter, Mark S. ;
Miller, Leslie W. ;
McGee, Edwin C. ;
Cotts, William G. ;
Acker, Michael A. ;
Jessup, Mariell L. ;
Gregoric, Igor D. ;
Loyalka, Pranav ;
Frazier, O. H. ;
Jeevanandam, Valluvan ;
Anderson, Allen S. ;
Kormos, Robert L. ;
Teuteberg, Jeffrey J. ;
Levy, Wayne C. ;
Naftel, David C. ;
Bittman, Richard M. ;
Pagani, Francis D. ;
Hathaway, David R. ;
Boyce, Steven W. .
CIRCULATION, 2012, 125 (25) :3191-+
[2]   ADAMTS13 activity is decreased in a septic porcine model Significance for glomerular thrombus deposition [J].
Bockmeyer, Clemens L. ;
Reuken, Philipp A. ;
Simon, Tim P. ;
Budde, Ulrich ;
Loesche, Wolfgang ;
Bauer, Michael ;
Birschmann, Ingvild ;
Becker, Jan U. ;
Marx, Gernot ;
Claus, Ralf A. .
THROMBOSIS AND HAEMOSTASIS, 2011, 105 (01) :145-153
[3]   Acquired von Willebrand Syndrome in Continuous-Flow Ventricular Assist Device Recipients [J].
Crow, Sheri ;
Chen, Dong ;
Milano, Carmelo ;
Thomas, William ;
Joyce, Lyle ;
Piacentino, Valentino, III ;
Sharma, Riti ;
Wu, Jogin ;
Arepally, Gowthami ;
Bowles, Dawn ;
Rogers, Joseph ;
Villamizar-Ortiz, Nestor .
ANNALS OF THORACIC SURGERY, 2010, 90 (04) :1263-1269
[4]   Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device [J].
Demirozu, Zumrut T. ;
Radovancevic, Rajko ;
Hochman, Lyone F. ;
Gregoric, Igor D. ;
Letsou, George V. ;
Kar, Biswajit ;
Bogaev, Roberta C. ;
Frazier, O. H. .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (08) :849-853
[5]   Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease [J].
Geisen, Ulrich ;
Heilmann, Claudia ;
Beyersdorf, Friedhelm ;
Benk, Christoph ;
Berchtold-Herz, Michael ;
Schlensak, Christian ;
Budde, Ulrich ;
Zieger, Barbara .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2008, 33 (04) :679-684
[6]  
GILL JC, 1987, BLOOD, V69, P1691
[7]   European results with a continuous-flow ventricular assist device for advanced heart-failure patients [J].
Lahpor, Jaap ;
Khaghani, Asghar ;
Hetzer, Roland ;
Pavie, Alain ;
Friedrich, Ivar ;
Sander, Kaare ;
Strueber, Martin .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2010, 37 (02) :357-361
[8]   Acquired von Willebrand Syndrome in Patients With an Axial Flow Left Ventricular Assist Device [J].
Meyer, Anna L. ;
Malehsa, Doris ;
Bara, Christoph ;
Budde, Ulrich ;
Slaughter, Mark S. ;
Haverich, Axel ;
Strueber, Martin .
CIRCULATION-HEART FAILURE, 2010, 3 (06) :675-681
[9]   Experimental study on shear stress distributions in a centrifugal blood pump [J].
Mizunuma, Hiroshi ;
Nakajima, Ryou .
ARTIFICIAL ORGANS, 2007, 31 (07) :550-559
[10]   Proteolysis of von Willebrand factor and shear stress-induced platelet aggregation in patients with aortic valve stenosis [J].
Pareti, FI ;
Lattuada, A ;
Bressi, C ;
Zanobini, M ;
Sala, A ;
Steffan, A ;
Ruggeri, ZM .
CIRCULATION, 2000, 102 (11) :1290-1295